PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Task Force for Combating the Corona Virus (COVID-19), Riffa, Bahrain. mqahtani@rcsi-mub.com.\', \'Bahrain Defence Force Hospital, Riffa, Bahrain. mqahtani@rcsi-mub.com.\', \'Royal College of Surgeons in Ireland, Riffa, Bahrain. mqahtani@rcsi-mub.com.\', \'Royal College of Surgeons in Ireland, Riffa, Bahrain.\', \'Salmaniya Medical Complex, Manama, Bahrain.\', \'National Task Force for Combating the Corona Virus (COVID-19), Riffa, Bahrain.\', \'Sheikh Mohammed Bin Khalifa Cardiac Centre, Riffa, Bahrain.\', \'Bahrain Defence Force Hospital, Riffa, Bahrain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-022-08794-w
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35322077
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all